文献速递慢性肾脏病

慢性肾脏病快速进展的危险因素分析

Risk factor analysis for a rapid progression of chronic kidney disease.
PubMed 文献 · Nephrol Dial Transplant · 2024-01-01

结果显示3年快速进展风险为14.6%,且风险从无危险因素女性的7%至合并严重白蛋白尿、糖尿病和高血压/心血管病者的46%-47%不等。

要点

  • 新发CKD G3期患者3年快速进展风险为14.6%,肾衰竭风险仅0.3%。
  • 合并严重白蛋白尿、糖尿病和高血压/心血管病者快速进展风险高达46%-47%。
  • 常规临床可获取的指标有助于识别快速进展高风险个体。

核心结论

  • 新发CKD G3期在社区人群中疾病负担显著,3年快速进展风险为14.6%。
  • 利用白蛋白尿、性别、糖尿病和高血压/心血管病等常规指标可识别快速进展高风险个体。

主要发现

  • 3年快速进展风险为14.6%(95%CI 14.4-14.8)。
  • 3年肾衰竭风险为0.3%(95%CI 0.3-0.4),住院风险为53.3%(95%CI 53.0-53.6),死亡风险为18.1%(95%CI 17.9-18.4)。
  • 快速进展风险从无白蛋白尿、高血压/心血管病和糖尿病的女性的7%至合并严重白蛋白尿、糖尿病和高血压/心血管病的男性和女性的46%-47%。

关键数值与推荐

  • 快速进展定义为经确认的估算肾小球滤过率年下降≥5 mL/min/1.73 m2。

临床怎么用

  • 在常规临床中可利用白蛋白尿、性别、糖尿病和高血压/心血管病等易获取指标评估CKD G3期患者快速进展风险。
  • 对高风险患者应优化预防性干预措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic kidney disease (CKD) is a growing global health concern. Identifying individuals in routine clinical care with new-onset CKD at high risk of rapid progression of the disease is imperative to guide allocation of prophylactic interventions, but community-based data are limited. We aimed to examine the risk of rapid progression, kidney failure, hospitalization and death among adults with incident CKD stage G3 and to clarify the association between predefined risk markers and rapid CKD progression. METHODS: Using plasma creatinine measurements for the entire Danish population from both hospitals and primary care, we conducted a nationwide, population-based cohort study, including adults in Denmark with incident CKD stage G3 in 2017-2020. We estimated 3-year risks of rapid progression (defined by a confirmed decline in estimated glomerular filtration rate of ≥5 mL/min/1.73 m2/year), kidney failure, all-cause hospitalization and death. To examine risk markers, we constructed a heat map showing the risk of rapid progression based on predefined markers: albuminuria, sex, diabetes and hypertension/cardiovascular disease. RESULTS: Among 133 443 individuals with incident CKD stage G3, the 3-year risk of rapid progression was 14.6% [95% confidence interval (CI) 14.4-14.8]. The 3-year risks of kidney failure, hospitalization and death were 0.3% (95% CI 0.3-0.4), 53.3% (95% CI 53.0-53.6) and 18.1% (95% CI 17.9-18.4), respectively. In the heat map, the 3-year risk of rapid progression ranged from 7% in females without albuminuria, hypertension/cardiovascular disease or diabetes, to 46%-47% in males and females with severe albuminuria, diabetes and hypertension/cardiovascular disease. CONCLUSION: This population-based study shows that CKD stage G3 is associated with considerable morbidity in a community-based setting and underscores the need for optimized prophylactic interventions among such patients. Moreover, our data highlight the potential of using easily accessible markers in routine clinical care to identify individuals who are at high risk of rapid progression.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Vestergaard AHS, Jensen SK, Heide-Jørgensen U, et al. Risk factor analysis for a rapid progression of chronic kidney disease. Nephrol Dial Transplant. 2024. PMID: 38168720. doi:10.1093/ndt/gfad271

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。